 |
市場調査レポート
商品コード
1321969
ヒアルロン酸の世界市場 - 市場規模、シェア、成長分析、用途別 - 産業予測（2023年～2030年）Global Hyaluronic Acid Market Size, Share, Growth Analysis, By Application(Dermal Fillers, Osteoarthritis) - Industry Forecast 2023-2030 |
||||||
| ヒアルロン酸の世界市場 - 市場規模、シェア、成長分析、用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年07月20日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のヒアルロン酸の市場規模は、2022年の94億米ドルから2030年までに168億米ドルに達し、予測期間（2023年～2030年）にCAGRで7.58%の成長が予測されています。
市場は、化粧品・医療部門からの需要の増加に牽引され、安定した成長を示しています。皮膚の健康を維持し、老化の兆候を抑えるヒアルロン酸の利点に対する意識の向上が、市場拡大を促進しています。また、技術の進歩と研究開発活動は、市場の成長可能性にさらに寄与しています。
促進要因
成形外科医や美容クリニックの急増により、美容手術の実施件数が増加しています。ボトックスやヒアルロン酸注入剤のような非外科的美容整形に対する需要の高まりが、ヒアルロン酸産業を牽引しています。
抑制要因
しかし、市場は競合の激化やセラミド、ビタミンCのような他のスキンケア化合物の人気の高まりによる課題に直面しています。さらに、スキンケア製品やヘアケア製品を中心とした厳しい規制が、当面の市場成長を妨げる可能性があります。
動向
市場は、高齢人口の増加と肥満の増加という2つの動向から恩恵を受けます。米国形成外科学会（ASAP）が報告しているように、ダーマルフィラー、特にヒアルロン酸から作られたものは、顔の軟部組織の異常への対処にもっとも一般的に使用されている非外科的注射処置です。これらのフィラーはしわを滑らかにし、目の下のくまを治療し、傷跡を最小限に抑え、皮膚を若返らせるために利用されています。これらの進歩は、市場の拡大を促進し、予測期間を通じてその成長を維持する見込みです。
当レポートでは、世界のヒアルロン酸市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界のヒアルロン酸市場：用途別
- 市場の概要
- だーまるフィラー
- 変形性関節症
- 眼科
- 膀胱尿管逆流
世界のヒアルロン酸の市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Allergan plc
- Anika Therapeutics, Inc.
- Ferring Pharmaceuticals
- Galderma S.A.
- Genzyme Corporation
- Hyaltech Ltd.
- LG Life Sciences Ltd.
- Medytox, Inc.
- Merz Pharma GmbH & Co. KGaA
- Salix Pharmaceuticals, Inc.
- Sanofi S.A.
- Seikagaku Corporation
- Shanghai Jingfeng Pharmaceutical Co., Ltd.
- Shiseido Company, Limited
- Sinclair Pharma plc
- Smith & Nephew plc
- Teva Pharmaceutical Industries Ltd.
- Valeant Pharmaceuticals International, Inc.
- Zimmer Biomet Holdings, Inc.
- AstraZeneca
Hyaluronic Acid Market size was valued at USD 8.74 billion in 2021 and is poised to grow from USD 9.4 billion in 2022 to USD 16.8 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).
The global hyaluronic acid market is experiencing steady growth, driven by increasing demand from the cosmetic and healthcare sectors. Hyaluronic acid, a natural substance found in the human body, is widely used in skincare products, dermal fillers, and joint treatments. The rising awareness about the benefits of hyaluronic acid in maintaining skin health and reducing signs of aging is fueling market expansion. Technological advancements and research and development activities are further contributing to the market's growth potential.
Top-down and bottom-up approaches were used to estimate and validate the size of Hyaluronic Acid and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
Hyaluronic Acid Marketis segmented on the basis of application and region. Based on application, the Hyaluronic Acid Market is segmented into Dermal Fillers, Osteoarthritis, Ophthalmic, and Vesicoureteral Reflux. Based on region, the global Hyaluronic acid market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Driver
The proliferation of plastic surgeons and cosmetic clinics has led to an increase in the number of aesthetic operations being performed. The growing demand for nonsurgical cosmetic procedures, such as Botox and hyaluronic acid injectables, is driving the hyaluronic acid industry.
Restrain
However, the hyaluronic acid market faces challenges due to rising competition and the growing popularity of other skincare compounds like ceramides and vitamin C. Additionally, strict regulations, particularly regarding skin and hair care products, could hinder the market's growth in the foreseeable future
Trend
The hyaluronic acid market stands to benefit from two prevailing trends: the increasing elderly population and the rising prevalence of obesity. Dermal fillers, particularly those made from hyaluronic acid, are the most commonly used nonsurgical injectable procedures for addressing facial soft tissue abnormalities, as reported by the American Society of Plastic Surgeons (ASAPS). These fillers are utilized to smoothen wrinkles and creases, treat under-eye dark circles, minimize scars, and rejuvenate the skin. These advancements are expected to drive the expansion of the hyaluronic acid market and sustain its growth throughout the projected period.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Hyaluronic Acid Market by Application
- Market Overview
- Dermal Fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral Reflux
- Global Hyaluronic Acid Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anika Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galderma S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genzyme Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hyaltech Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LG Life Sciences Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medytox, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merz Pharma GmbH & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Salix Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Seikagaku Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai Jingfeng Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shiseido Company, Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sinclair Pharma plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith & Nephew plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Valeant Pharmaceuticals International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
